Syneron Bio
Next-generation macrocyclic peptide therapeutics powered by the Synova™ platform
Beijing, United States · Founded 2022 · $250.0M raised
- Headquarters
- Beijing
- Employees
- 51–200
- Founded
- 2022
- Business Model
- B2B
- Website
- syneronbio.com
- Total Funding
- $250.0M
- Last Round
- $150.0M Series BApr 2026
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 19 investors for this company. The full record is or through the API.
About
Syneron Bio is a Beijing-based biotech company dedicated to the development of next-generation macrocyclic peptide therapeutics, leveraging artificial intelligence and drug synthesis technology. The company has completed Series A, A+, and Series B financing rounds totaling approximately $400M, with backers including AstraZeneca. It operates in the intersection of AI and synthetic biology for drug discovery.
Summary
Syneron Bio is a Biotech company based in Beijing, United States, founded in 2022. It has raised $250.0M in total across 2 rounds, most recently a $150.0M Series B round in Apr 2026. Investors include ARCH Venture Partners, Lilly Asia Ventures and Tencent.
Funding History
Apr 2026
Sign up to see all 2 events
Funding: Series A through Series B. Amounts, valuations, and investors where available.
Investors
ARCH Venture Partners
1 round
Lilly Asia Ventures
1 round
Tencent
1 round
AstraZeneca
1 round
AZ-CICC Healthcare Investment Fund
1 round
Pfizer Biotech Development Investment Fund
1 round
Frazier Life Sciences
1 round
Novartis Venture Fund
1 round
OrbiMed
1 round
Alexandria Venture Investments
1 round
Decheng Capital
1 round
CDH Investments
1 round
True Light Capital
1 round
Lenovo Capital and Incubator Group
1 round
GL Ventures
1 round
5Y Capital
1 round
Sinovation Ventures
1 round
GREE Ventures
1 round
KHK Fund
1 round
Similar Companies
Neuralink develops investigational implantable brain-computer interfaces that help people with pa...
Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/syneron-bio"><img src="https://indexed.vc/api/badge/company/syneron-bio" alt="Syneron Bio on Indexed.vc" width="260" height="76" /></a>